{"id":"https://openalex.org/W2010123263","doi":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","title":"Abstract P2-09-19: Expression Profiling of a Metastasis Score and a \u201cGlycolytic Index\u201d in Genetically-Defined Human Breast Isogenic Cell Lines Treated with a PI3K Inhibitor","display_name":"Abstract P2-09-19: Expression Profiling of a Metastasis Score and a \u201cGlycolytic Index\u201d in Genetically-Defined Human Breast Isogenic Cell Lines Treated with a PI3K Inhibitor","alternate_titles":[],"publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W2010123263","doi":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","mag":"2010123263"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.sabcs10-p2-09-19","doi":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010123263"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110210949","display_name":"Cindy Christopherson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Christopherson","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109347650","display_name":"Susan Rigby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Rigby","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036866151","display_name":"A Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Wang","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012511828","display_name":"ROBERT J. LAGIER","orcid":"https://orcid.org/0000-0002-0053-7305","observed_orcids":["https://orcid.org/0000-0002-0053-7305"]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Lagier","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074964557","display_name":"John J. Sninsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J Sninsky","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047761107","display_name":"S. Kwok","orcid":"https://orcid.org/0009-0008-5727-0833","observed_orcids":["https://orcid.org/0009-0008-5727-0833"]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Kwok","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108750510","display_name":"Christopher J. Torrance","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095126","display_name":"Horizon Discovery (United Kingdom)","ror":"https://ror.org/00q2y5s03","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210095126","https://openalex.org/I43591049","https://openalex.org/I4405255244"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Torrance","raw_affiliation_strings":["Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","Celera Corporation, Alameda, CA","Hypoxium, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celera Corporation, Alameda, CA; Hypoxium, Cambridge, United Kingdom; Horizon Discovery Ltd, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I4210095126"]},{"raw_affiliation_string":"Celera Corporation, Alameda, CA","institution_ids":[]},{"raw_affiliation_string":"Hypoxium, Cambridge, United Kingdom","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210095126"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"24_Supplement","first_page":"P2","last_page":"09"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.48539999127388,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.48539999127388,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.4794999957084656,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11339","display_name":"Metabolism, Diabetes, and Cancer","score":0.02630000002682209,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/isogenic-cell-lines","display_name":"isogenic cell lines","score":0.800000011920929},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/gdc-0941","display_name":"GDC-0941","score":0.9710000157356262},{"id":"https://openalex.org/keywords/glycolysis","display_name":"glycolysis","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.6209999918937683},{"id":"https://openalex.org/keywords/kras-g12v","display_name":"KRAS G12V","score":0.7440000176429749},{"id":"https://openalex.org/keywords/cdk1","display_name":"CDK1","score":0.6940000057220459},{"id":"https://openalex.org/keywords/cell-cycle-regulation","display_name":"cell cycle regulation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/tumor-metabolism","display_name":"cancer metabolism","score":0.5690000057220459},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.7599999904632568},{"id":"https://openalex.org/keywords/mcf10a","display_name":"MCF10A","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6563578248023987},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6230539679527283},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5927789211273193},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5897039175033569},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5773192048072815},{"id":"https://openalex.org/C20251656","wikidata":"https://www.wikidata.org/wiki/Q162643","display_name":"Glycolysis","level":3,"score":0.526395320892334},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.5104821920394897},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.48140788078308105},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4712189733982086},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4704652726650238},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4034208655357361},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39048901200294495},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.38513684272766113},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.32148414850234985},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2094936966896057},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.1753934621810913},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1556943655014038}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.sabcs10-p2-09-19","doi":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.sabcs10-p2-09-19","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2018857991","https://openalex.org/W2011944933","https://openalex.org/W2316833300","https://openalex.org/W2329361567","https://openalex.org/W2401997345","https://openalex.org/W2065962324","https://openalex.org/W3114996551","https://openalex.org/W4220787076","https://openalex.org/W2607291180","https://openalex.org/W2052589518"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Activation":[2],"of":[3,7,17,57,105,108,155,180,241,258,332,377,403,410,425],"signaling":[4],"pathways,":[5],"loss":[6],"tumor":[8,69,480],"suppressors":[9],"and":[10,19,33,49,63,72,79,86,96,117,147,175,189,198,205,223,234,244,262,277,298,323,338,360,373,389,438],"oncogenic":[11,447],"mutations":[12,448],"often":[13],"lead":[14],"to":[15,38,194,451,468],"dysregulation":[16],"glycolysis":[18],"tumorigenesis.":[20],"We":[21],"performed":[22,150],"expression":[23,148,257,294,383],"analysis":[24,149],"on":[25,41,75],"genetically-defined":[26],"human":[27],"isogenic":[28,88],"breast":[29],"cancer":[30],"cell":[31,70,89,132,211,308,366,378,441],"lines":[32,90,133,212,367,442],"with":[34,122,144,191,246,288,302,318],"PI3K":[35,249,396],"inhibitor":[36,397],"exposure":[37],"determine":[39],"impact":[40],"a":[42,165,199,227,248,252,304],"patient-relevant":[43],"Metastasis":[44],"Score":[45],"(MS)":[46,168],"(proliferation":[47],"index)":[48],"an":[50,137,196,369],"assembled":[51],"\u201cglycolytic":[52,200,229,316,340,361],"index\u201d.":[53,201],"A":[54,83,153],"better":[55],"understanding":[56],"the":[58,103,186,208,216,242,256,263,269,278,289,315,319,339,348,358,364,386,404,407,426,456,462,479],"links":[59],"between":[60,275,357,371],"cellular":[61],"metabolism":[62,374],"proliferation":[64,372,411,432],"may":[65,415],"yield":[66,195],"insights":[67],"into":[68],"biology":[71],"shed":[73],"light":[74],"potential":[76],"companion":[77],"diagnostic":[78],"therapeutic":[80,422],"opportunities.":[81],"Methods:":[82],"parental":[84,116,222,243,349],"MCF10A":[85,437],"three":[87,439],"harboring":[91],"K-ras":[92,235],"(G12V),":[93],"PI3K\u03b1":[94,118,224,245,346],"(H1047R),":[95],"p53":[97,232],"null":[98,233],"were":[99,120,134,158,213],"grown":[100,471],"overnight":[101],"in":[102,111,164,255,286,293,307,328,345,385,420,435,457,472],"presence":[104],"high":[106],"levels":[107,433],"growth":[109],"factors":[110],"tissue":[112],"culture":[113,218],"flasks.":[114],"The":[115,203,221,272,283,311,330,353,381,430],"cells":[119,225,236,350,470],"treated":[121,365],"0.3":[123],"\u00b5M,":[124],"1":[125],"\u00b5M,3":[126],"\u00b5M":[127],"GDC-0941":[128],"or":[129,454],"DMSO.":[130],"All":[131],"incubated":[135],"for":[136,207],"additional":[138],"24":[139],"hr.":[140],"RNA":[141],"was":[142,183,281,342],"extracted":[143],"RNeasy":[145],"(Qiagen)":[146],"by":[151,336],"RT-PCR.":[152],"total":[154],"28":[156],"genes":[157,163,174,261,265,285,313],"profiled":[159],"that":[160,394,445,455,475],"included":[161],"14":[162],"metastasis":[166],"score":[167],"(Tutt":[169],"et":[170],"al),":[171],"11":[172],"glycolysis-associated":[173],"3":[176],"reference":[177],"genes.":[178],"Expression":[179],"each":[181],"gene":[182],"calculated":[184],"using":[185],"\u0394\u0394CT":[187],"method":[188],"\u201csummed\u201d":[190],"equal":[192],"weighting":[193],"MS":[197,204,260,276,287,337,359,453],"Results:":[202],"phenotypes":[206],"four":[209,284],"untreated":[210,436],"similar":[214,228,431],"under":[215],"monolayer":[217],"conditions":[219,459],"used.":[220],"had":[226,237],"index\u201d":[230,317,341],"while":[231],"elevated":[238],"indices.":[239],"Treatment":[240],"GDC-0941,":[247,333],"inhibitor,":[250],"showed":[251],"dose-dependent":[253,291,382],"decrease":[254,292],"constituent":[259,391],"glycolytic":[264,279],"as":[266,268,334,417],"well":[267],"combined":[270],"scores.":[271],"correlation":[273,355],"coefficient":[274],"index":[280,362],"0.77.":[282],"greatest":[290,320],"(BUB1,":[295],"CCNB1,":[296],"MYBL2":[297],"UBE2S)":[299],"are":[300,325,449,460,466],"associated":[301],"CDK1,":[303],"seminal":[305],"participant":[306],"cycle":[309],"regulation.":[310],"two":[312,387],"from":[314],"decrease,":[321],"HK":[322],"PKM,":[324],"directly":[326],"involved":[327],"glycolysis.":[329],"effect":[331],"reflected":[335],"more":[343,476],"pronounced":[344],"than":[347],"(p-value=0.0005).":[351],"Conclusion:":[352],"good":[354],"observed":[356,434],"\u201cin":[363],"supports":[368],"association":[370],"upon":[375],"restriction":[376],"signal":[379],"transduction.":[380],"decreases":[384],"indices":[388],"their":[390],"genes,":[392],"suggest":[393,443],"this":[395],"successfully":[398],"perturbs":[399],"both":[400],"fundamental":[401],"processes":[402],"cell.":[405],"Given":[406],"ultimate":[408],"targeting":[409],"suppression,":[412],"these":[413],"scores":[414],"serve":[416],"useful":[418],"tools":[419],"evaluating":[421],"agents,":[423],"independent":[424],"specific":[427],"intended":[428],"pathways.":[429],"mutated":[440],"either":[444],"single":[446],"insufficient":[450],"affect":[452],"vitro":[458],"masking":[461],"metastatic/invasive":[463],"phenotype.":[464],"Studies":[465],"underway":[467],"evaluate":[469],"3D":[473],"Matrigel":[474],"accurately":[477],"mimic":[478],"microenvironment.":[481],"Citation":[482],"Information:":[483],"Cancer":[484],"Res":[485],"2010;70(24":[486],"Suppl):Abstract":[487],"nr":[488],"P2-09-19.":[489]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010123263","counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}
